)

SanBio Company (4592) investor relations material
SanBio Company Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Focused on advancing regenerative medicine, particularly with AKUUGO® for brain regeneration and SB623 for traumatic brain injury and stroke, achieving conditional approval for AKUUGO® in Japan and progressing toward commercialization.
Three major achievements: regulatory progress in Japan, agreement with FDA on US phase III trial, and securing new bank credit lines.
Strategic growth pillars include Japan as a base, restarting US clinical initiatives, and expanding into ischemic stroke treatment.
R&D expenses reached ¥1,346 million, mainly for AKUUGO® approval-related activities.
Financial highlights
Operating expenses increased to ¥1,888 million in Q2 FY2026.1, mainly due to AKUUGO® approval activities.
Net loss widened to ¥1,997 million in Q2 FY2026.1, an increase of ¥688 million year-over-year.
Cash and cash equivalents at period-end were ¥2,372 million, down ¥480 million from prior year-end.
Operating expenses revised upward for the full year to ¥3,920 million due to increased manufacturing costs.
No dividends declared or forecasted for the fiscal year.
Outlook and guidance
Full-year forecast revised: operating loss expected at ¥3,920 million, ordinary loss at ¥4,530 million, and net loss at ¥4,045 million.
Anticipates partial change approval for AKUUGO® in Japan between August and January, with drug price listing and product sales expected in the first half of next year.
US phase III TBI trial design agreed with FDA; preparations for trial to begin in the next fiscal year.
Plans to expand AKUUGO® indications to stroke, spinal cord injury, retinal disease, Parkinson's, and Alzheimer's.
Four-year vision includes US product launch and substantial progress in stroke program.
Next SanBio Company earnings date

Next SanBio Company earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage